← FDA DRUG APPROVALS

FDA ANDA · ANDA087449

THEOPHYLLINE

Sponsor: ROXANE

APPLICATION
ANDA087449
TYPE
ANDA
ORIGINAL APPROVAL
1983-09-15
LATEST ACTION
1999-02-01
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

THEOPHYLLINE · ReferenceDiscontinued
THEOPHYLLINE 80MG/15ML · SOLUTION · ORAL

Approval history

1999-02-01Manufacturing (CMC) · Supplement 13AP
1998-09-15Manufacturing (CMC) · Supplement 15AP
1996-09-20Labeling · Supplement 12AP
1996-08-28Manufacturing (CMC) · Supplement 11AP
1996-08-28Manufacturing (CMC) · Supplement 10AP
1996-08-28Manufacturing (CMC) · Supplement 9AP
1990-11-09Labeling · Supplement 8AP
1988-03-24Manufacturing (CMC) · Supplement 6AP
1988-03-24Manufacturing (CMC) · Supplement 7AP
1986-07-10Manufacturing (CMC) · Supplement 1AP
1986-07-10Manufacturing (CMC) · Supplement 2AP
1983-09-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →